期刊文献+

ICU感染患者中非发酵菌分布与耐药性分析 被引量:4

Distribution and drug resistance of non-fermenting bacteria isolated from ICU patients with infections
原文传递
导出
摘要 目的分析重症监护病房(ICU)感染患者中非发酵菌的分布及耐药性,为临床抗感染治疗提供依据。方法选取2013年6月-2015年6月ICU住院患者200例作为研究对象,采集患者的各类标本并对其中的非发酵菌进行菌种鉴定和药敏试验。结果在各类标本中,共分离出非发酵菌253株,其中,痰液和引流液中的非发酵菌构成比最高,分别占47.4%和12.3%;在分离出的非发酵菌中,以铜绿假单胞菌、鲍氏不动杆菌、嗜麦芽寡养单胞菌的构成比最高,分别占38.7%、28.1%和22.9%;分离出的主要非发酵菌对于常用抗菌药物具有较高的耐药率,铜绿假单胞菌对阿米卡星、妥布霉素、头孢哌酮/舒巴坦较敏感,耐药率<25.0%,鲍氏不动杆菌对头孢哌酮/舒巴坦、阿米卡星、米诺环素较敏感,耐药率<43.0%,嗜麦芽寡养单胞菌对米诺环素、头孢哌酮/舒巴坦、左氧氟沙星较敏感,耐药率<28.0%。结论 ICU住院患者中非发酵菌的分布和耐药性具有一定的特征,临床医师应准确识别,及时监控其变化趋势,选取敏感抗菌药物进行抗感染治疗,从而达到提高治疗效果、改善患者预后的目的。 OBJECTIVE To analyze the distribution and drug resistance of non-fermenting bacteria isolated from patients with infections in intensive care unit(ICU)so as to provide guidance for clinical treatment of the infections.METHODS A total of 200 patients who were hospitalized in the ICU from Jun 2013 to Jun 2015 were recruited as the study objects,then the specimens were collected from the enrolled patients,the isolated non-fermenting bacteria were identified,and the drug susceptibility testing was performed.RESULTS Totally 253 strains of non-fermenting bacteria were isolated from the specimens,of which 47.4% were isolated from sputum specimens,and 12.3%were isolated from drainage fluid.Among the isolated non-fermenting bacteria,the Pseudomonas aeruginosa,Acinetobacter baumannii,and Stenotrophomonas maltophilia accounted for 38.7%,28.1%,and 22.9%,respectively.The major species of the isolated non-fermenting bacteria were highly resistant to the commonly used antibiotics;the drug resistance rates of the P.aeruginosato amikacin,tobramycin,and cefoperazone-sulbactam were less than 25.0%;the A.baumannii strains were susceptible to cefoperazone-sulbactam,amikacin,and minocycline,with the drug resistance rates less than 43.0%;the drug resistance rates of the S.maltophiliato minocycline,cefoperazone-sulbactam,and levofloxacin were less than 28.0%.CONCLUSION The distribution and drug resistance of the non-fermenting bacteria isolated from the hospitalized ICU patients show certain characteristics,and it is necessary for the clinicians to accurately identify,monitor the changes in a timely manner,and choose sensitive antibiotics for treatment of the infections so as to raise the therapeutic effect and improve the prognosis of the patients.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第17期3866-3868,共3页 Chinese Journal of Nosocomiology
基金 浙江省医药卫生科技计划基金资助项目(2014KYA190)
关键词 重症监护病房 非发酵菌 菌种分布 耐药性分析 Intensive care unit Non-fermenting bacteria Distribution of species Analysis of drug resistance Nosocomial infection
  • 相关文献

参考文献8

  • 1Wallace MC,Macy DL.Reduction of central line-associated bloodstream infection rates in patients in the adult intensive care unit[J].J Infus Nurs,2016,39(1):47-55.
  • 2Han JH,Nachamkin I,Coffin SE,et al.Use of a combination biomarker algorithm to identify medical intensive care unit patients with suspected sepsis at very low likelihood of bacterial infection[J].Antimicrob Agents Chemother,2015,59(10):6494-6500.
  • 3Mladenovic J,Veljovic M,Udovicic I,et al.Catheter-associated urinary tract infection in a surgical intensive care unit[J].Vojnosanit Pregl,2015,72(10):883-888.
  • 4Dubost C,Pasquier P,Kearns K,et al.Preparation of an intensive care unit in France for the reception of a confirmed case of Ebola virus infection[J].Anaesth Crit Care Pain Med,2015,34(6):349-355.
  • 5Shen JL,Fang YP.Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to apersister during carbapenem treatment[J].Genet Mol Res,2015,14(2):6723-6732.
  • 6郑璇儿,杨杰.铜绿假单胞菌耐药性的基因学研究进展[J].中华实验和临床感染病杂志(电子版),2014,8(1):111-113. 被引量:15
  • 7李娟,罗斌,姚新宝,郭淑丽,韩雪.鲍氏不动杆菌的临床分布与耐药性变迁[J].中华医院感染学杂志,2015,25(18):4098-4100. 被引量:3
  • 8张丽红,朱步海,徐修礼,丁双双,李冰心,黄洋,樊一笋.鲍氏不动杆菌的临床分布与耐药基因分析研究[J].中华医院感染学杂志,2015,25(16):3629-3631. 被引量:3

二级参考文献42

  • 1徐英春,陈民钧.AmpC酶与革兰阴性菌的耐药特征[J].中华微生物学和免疫学杂志,2001,21(S1):18-20. 被引量:24
  • 2周丹秋,李敏,蒋晓飞,阮斐怡,刘红,吕元.全耐药铜绿假单胞菌中多药外排泵mRNA表达的定量RT-PCR检测[J].临床检验杂志,2006,24(2):103-105. 被引量:11
  • 3Parker CM, Kutsogiannis J, Muscedere J, et al. Canadian CriticalCare Trials Group. Ventilator-associated pneumonia caused bymultidrug-resistant organisms or Pseudomonas aeruginosa:prevalence, incidence, risk factors, and outcomes[J]. J CritCare,2008,23(1):18-26.
  • 4ElSolh AA, Alhajhusain A. Update on the treatment ofPseudomonas aeruginosa pneumonia[J}. J AntimicrobChemother,2009,64(2):229-238.
  • 5Mima T, Sekiya H, Mizushima T, et al. Gene cloning andproperties of the RND-type multidrug efflux pumps MexPQ-OpmE and MexMN-OprM from Pseudomonas aeruginosa[J].Microbiol Immunol,2005,49(11):999-1002.
  • 6Schweizer HP. Efflux as a mechanism of resistance toantimicrobials in Pseudomonas aeruginosa and related bacteria:unanswered questions[J], Genet Mol Res,2003,2(1 ):48-62.
  • 7Hocquet D, Nordmann P, El Garch F, et al. Involvement of theMexXY-OprM efflux system in emergence of cefepime resistancein clinical strains of Pseudomonas aeruginosa[J]. AntimicrobAgents Chemother,2006,50(4): 1347-1351.
  • 8Piddock LJ. Clinically relevant chromosomally encodedmultidrug resistance efflux pumps in bacteria[J]. Clin MicrobiolRev,2006,19(2):382-402.
  • 9MaoW, Warren MS, Lee A, et al. MexXY-OprM efflux pumpis required for antagonism of aminoglycosides by divalentcations in Pseudomonas aeruginosa[J]. Antimicrob AgentsChemother,2001,45(7):2001-2007.
  • 10Shinabarger DL, Marotti KR, Murray RW, et al. Mechanism of actionof oxazolidinones; effects of linezolid and eperzolid on translationreactions[J], Antimicrob Agents Chemother, 1997,41 (10):2132-2136.

共引文献18

同被引文献28

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部